Our researchers are fighting the coronavirus pandemic with innovative approaches. With your donation you can support them in developing drugs and vaccines against the virus or in deciphering the mechanisms of disease development and progression. Here you can find out all about donation opportunities.
Here you can find out more about the scientific results of the HZI in the research topics ”Bacterial and Viral Pathogens”, “Immune Response and Interventions” and “Anti-Infectives”.
Around 900 employees in research, administration and infrastructure, and about 220 visiting scientists from 40 different countries are employed at the Helmholtz Centre for Infection Research. To ensure top quality research we need top quality employees. Your creativity and innovative capabilities are the basis for the long-term success of our work. That's why we undertake a great deal to attract the best people to us. Learn more about this.
We communicate also through social media. Join our Facebook page, follow us on Twitter or subscribe to our YouTube-Channel.
The coronaviruses are a family of viruses that includes a series of very different pathogens. These viruses usually infect mammals, rodents, and birds, but only few coronaviruses adapted to humans. They did this with great success: About one third of all typical "common colds" and some cases of diarrhoea as well are caused by these RNA Viruses, which are the largest of their kind. We have compiled more information about the coronaviruses for you.
With the pathogen SARS-CoV-2, a novel virus that can cause respiratory diseases and pneumonia has been spreading worldwide since the end of 2019. Here we will keep you informed about current developments in research and provide answers to the most important questions.
HomeNews & EventsNews
Results 1 to 10 of total 473
2021-10-06
New concept aims to develop broadly effective therapeutics against viruses
2021-10-01
The Helmholtz Institute for Pharmaceutical Research Saarland and Saarland University will cooperate even more closely in the future
2021-09-22
Research organisations join forces to respond to societal challenges
2021-09-13
Record attendance at the webinar
2021-08-31
Researchers from the Department of Microbial Natural Products improve the production of a new drug candidate
2021-08-30
On 22 September 2021, partner institutions will present career opportunities
2021-08-20
International research alliance proposes strategy for the discovery and development of new active substances
2021-08-11
Three international Alexander von Humboldt fellows join the HIPS for one year
2021-08-02
HIRI and JMU Würzburg create first RNA atlas of Fusobacterium nucleatum
2021-07-15
TWINCORE researchers show how communication between immune cells determines response to vaccination
2021-10-18
2021-10-16
2021-10-14
